All sites C00-96,D32-33,D42-43,D45-47,D76 603 89.3 2.7 2.6 3.3 2.2
Mouth, pharynx C00-14 11 98.1 - - 1.9 -
  Lip C00 1 100.0 - - - -
  Tongue C02 3 100.0 - - - -
  Mouth, other C03-06 4 94.4 - - 5.6 -
  Salivary glands C07-08 1 100.0 - - - -
  Pharynx C01,C09-14 3 100.0 - - - -
Digestive organs C15-26 112 80.2 2.5 6.1 7.5 3.7
  Oesophagus C15 3 100.0 - - - -
  Stomach C16 12 84.5 1.7 1.7 6.9 5.2
  Small intestine C17 1 85.7 - - 14.3 -
  Colon C18 40 95.5 - 1.0 2.5 1.0
  Rectum, rectosigmoid C19-20 19 94.8 - - 3.1 2.1
  Anus C21 1 100.0 - - - -
  Liver C22 6 75.0 6.3 9.4 9.4 -
  Gallbladder, bile ducts C23-24 6 67.7 6.5 6.5 12.9 6.5
  Pancreas C25 22 41.4 8.1 23.4 19.8 7.2
  Other digestive organs C26 1 42.9 - - - 57.1
Respiratory organs C30-39 39 66.0 10.2 9.1 9.1 5.6
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 1 100.0 - - - -
  Lung, trachea C33-34 38 64.4 10.6 9.6 9.6 5.9
  Mediastinum, pleura C38 - - - - - -
Bone C40-41 1 100.0 - - - -
Melanoma of the skin C43 26 100.0 - - - -
Skin, non-melanoma C44 39 100.0 - - - -
Mesothelioma C45 0 100.0 - - - -
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 4 90.5 - - 9.5 -
Breast C50 174 98.9 1.0 - 0.1 -
Female genital organs C51-58 67 92.0 2.1 1.8 2.4 1.8
  Cervix uteri C53 7 97.0 - 3.0 - -
  Corpus uteri C54 28 100.0 - - - -
  Uterus, other C55,C58 0 - - - 50.0 50.0
  Ovary C56 24 83.6 4.1 4.1 4.9 3.3
  Other female genital C51-52,C57 8 89.7 5.1 - 2.6 2.6
Urinary organs C64-68 28 89.4 - 2.8 4.3 3.5
  Kidney C64 16 85.4 - 3.7 7.3 3.7
  Bladder and urinary tract2 C65-68 12 94.9 - 1.7 - 3.4
Eye C69 0 50.0 - - 50.0 -
Brain, central nervous system C70-72,D32-33,D42-43 20 93.9 - 2.0 2.0 2.0
Thyroid gland C73 10 95.8 4.2 - - -
Other endocrine glands C74-75 1 66.7 - - - 33.3
Illdefined or unknown C76,C80 15 58.7 8.0 12.0 14.7 6.7
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 56 82.4 7.9 1.8 2.2 5.7
  Hodgkin lymphoma C81 1 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 22 98.2 0.9 - 0.9 -
  Malignant immunoproliferative diseases C88 1 66.7 - 33.3 - -
  Myeloma and other plasma cell tumors C90 9 77.8 6.7 8.9 4.4 2.2
  Leukaemia C91-95 11 63.6 25.5 - 1.8 9.1
  Myelodysplastic syndromes D46 2 36.4 9.1 - - 54.5
  Myeloproliferaitive neoplasms D45,D47 10 81.6 6.1 - 4.1 8.2
Not included above
  Carcinoma in situ of the breast D05 12 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 11 100.0 - - - -
  Borderline tumour of the ovary D39 3 94.1 - - 5.9 -
  Basal cell carcinoma of the skin 164 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.